Published in Martin Paul Eve

Like many years, 2022 was a year of health problems for me. The entire year has been overshadowed by the episode of kidney failure that I suffered as a result of BK virus associated nephropathy. It is fair to say that I have been quite seriously unwell. I also spent a long period of this year, in my spare time, campaigning for protection of the immunocompromised with the monoclonal antibody therapy, Evusheld.